DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Mccaughan G, Roberts S, Strasser S. , et al.
The Toscar study: sofosbuvir and daclatasvir therapy for decompensated HCV cirrhosis with MELD scores≥ 15.
J Gastroenterol Hepatol 2015;
30: 89
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.